Garden State Investment Advisory Services LLC Invests $228,000 in Omega Healthcare Investors, Inc. (NYSE:OHI)

Garden State Investment Advisory Services LLC purchased a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 5,602 shares of the real estate investment trust’s stock, valued at approximately $228,000.

Several other institutional investors also recently bought and sold shares of OHI. State Street Corp grew its holdings in Omega Healthcare Investors by 0.9% during the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust’s stock valued at $502,228,000 after purchasing an additional 114,085 shares in the last quarter. Geode Capital Management LLC boosted its position in Omega Healthcare Investors by 3.1% in the 3rd quarter. Geode Capital Management LLC now owns 6,426,129 shares of the real estate investment trust’s stock valued at $261,589,000 after buying an additional 192,465 shares during the last quarter. FMR LLC increased its position in shares of Omega Healthcare Investors by 9.9% during the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after acquiring an additional 380,626 shares during the last quarter. Daiwa Securities Group Inc. lifted its stake in shares of Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after acquiring an additional 3,003,845 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Omega Healthcare Investors by 6.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock valued at $155,893,000 after purchasing an additional 240,006 shares during the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Omega Healthcare Investors

In related news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Omega Healthcare Investors Trading Up 1.0 %

Omega Healthcare Investors stock opened at $39.20 on Friday. The firm has a 50-day moving average price of $40.38 and a two-hundred day moving average price of $37.82. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42. The firm has a market capitalization of $10.58 billion, a price-to-earnings ratio of 28.82, a PEG ratio of 1.21 and a beta of 0.98. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.84%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Analyst Ratings Changes

Several equities research analysts have issued reports on OHI shares. Royal Bank of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective on the stock in a research note on Monday, December 9th. Truist Financial boosted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Finally, Mizuho lifted their price target on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research note on Thursday, December 5th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $40.18.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.